Wegovy is covered for the cardiovascular indication (CVD plus overweight or obesity) following the CMS coverage update in March 2024, not for weight loss alone
Additionally, we might find that our body adapts to the lower doses, and hunger can increase
Clinical and biochemical effects
If youre like us, and your brain immediately tunes out at the sound of oxidized carboxylation something-something, this handy little 47 second video can explain everything: Basically, think of it like this
h , Bar graph summarizing the effect of NMDA-induced inward current after control (aCSF, n = 5 neurons), GLP-1 (50 M, n = 5 neurons), MK-801 (50 M, n = 5 neurons) or GLP-1MK-801 (50 M, n = 5 neurons)
Cloudiness = contamination or damaged peptide